Abstract:Background and aim A plateau in oxygen uptake ( V ̇ O 2 ) during an incremental cardiopulmonary exercise test (CPET) to volitional exhaustion appears less likely to occur in special and clinical populations. Secondary maximal oxygen uptake ( V ̇ O 2 max ) criteria have been shown to commonly underestimate the actual V ̇ O 2 max . The verification phase protocol might determine the occurrence of ‘true’ V ̇ O 2 max in these populations. The primary aim of the current study was to systematically review and provide a meta-analysis on the suitability of the verification phase for confirming ‘true’ V ̇ O 2 max in special and clinical groups. Secondary aims were to explore the applicability of the verification phase according to specific participant characteristics and investigate which test protocols and procedures minimise the differences between the highest V ̇ O 2 values attained in the CPET and verification phase. Methods Electronic databases (PubMed, Web of Science, SPORTDiscus, Scopus, and EMBASE) were searched using specific search strategies and relevant data were extracted from primary studies. Studies meeting inclusion criteria were systematically reviewed. Meta-analysis techniques were applied to quantify weighted mean differences (standard deviations) in peak V ̇ O 2 from a CPET and a verification phase within study groups using random-effects models. Subgroup analyses investigated the differences in V ̇ O 2 max according to individual characteristics and test protocols. The methodological quality of the included primary studies was assessed using a modified Downs and Black checklist to obtain a level of evidence. Participant-level V ̇ O 2 data were analysed according to the threshold criteria reported by the studies or the inherent measurement error of the metabolic analysers and displayed as Bland-Altman plots. Results Forty-three studies were included in the systematic review, whilst 30 presented quantitative information for meta-analysis. Within the 30 studies, the highest mean V ̇ O 2 values attained in the CPET and verification phase protocols were similar (mean difference = -0.00 [95% confidence intervals, CI = -0.03 to 0.03] L·min -1 , p = 0.87; level of evidence, LoE: strong). The specific clinical groups with sufficient primary studies to be meta-analysed showed a similar V ̇ O 2 max between the CPET and verification phase ( p > 0.05, LoE: limited to strong). Across all 30 studies, V ̇ O 2 max was not affected by differences in test protocols ( p > 0.05; LoE: moderate to strong). Only 23 (53.5%) of the 43 reviewed studies reported how many participants achieved a lower, equal, or higher V ̇ O 2 value in the verification phase versus the CPET or reported or supplied participant-level V ̇ O 2 data for this information to be obtained. The percentage of participants that achieved a lower, equal, or higher V ̇ O 2 value in the verification phase was highly variable across studies (e.g. the percentage that achieved a higher V ̇ O 2 in the verification phase ranged from 0% to 88.9%). Conclusion Group-level verification phase data appear useful for confirming a specific CPET protocol likely elicited V ̇ O 2 max , or a reproducible V ̇ O 2 p e a k , for a given special or clinical group. Participant-level data might be useful for confirming whether specific participants have likely elicited V ̇ O 2 max , or a reproducible V ̇ O 2 p e a k , however, more research reporting participant-level data is required before evidence-based guidelines can be given. Trial registration PROSPERO ( CRD42021247658 ) https://www.crd.york.ac.uk/prospero .

Reliability of maximum oxygen uptake in cardiopulmonary exercise testing with continuous laryngoscopy

Different measures of ventilatory efficiency in preoperative cardiopulmonary exercise testing are useful for predicting postoperative complications in abdominal cancer surgery

The outcomes from introducing continuous laryngoscopy during exertion (CLE) to an exertional dyspnoea cardiopulmonary exercise testing (CPET) service.

Investigation of exertional dyspnoea by cardiopulmonary exercise testing with continuous laryngoscopy

ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases

Laryngeal response to high-intensity exercise in healthy athletes

Preliminary Study of Cpet in Patients with Central Airway Obstruction

The clinical value of cardiopulmonary exercise testing in the modern era

Confirming the attainment of maximal oxygen uptake within special and clinical groups: A systematic review and meta-analysis of cardiopulmonary exercise test and verification phase protocols

P310 CARDIOPULMONARY EXERCISE TEST IN THE EVALUATION OF A PATIENT WITH HFREF: THE IMPORTANCE IN THE ANALYSIS OF GAS KINETICS

Cardiopulmonary Exercise Testing with Elastic Resistance: A New Reproducible Proposal for Determination of Ventilatory Thresholds and Maximum Oxygen Consumption

Validity and repeatability of cardiopulmonary exercise testing in interstitial lung disease

Influence of the method of calculating the Ve / VCO2 slope on its value in a cohort of 700 successive Cardiopulmonary exercise testing

The Role of Cardiopulmonary Exercise Testing in Assessment of Patients with Interstitial Lung Disease

Cardiopulmonary exercise testing: current applications

The added value of cardiopulmonary exercise testing in the diagnosis of heart failure with preserved ejection fraction

Comparison of Physical Fitness and Cardiopulmonary Exercise Test Performance Using Arm Versus Leg Cycling in Patients With Cardiovascular or Pulmonary Disease–A Systematic Review and Meta-analysis

Regulating the larynx by expiratory pressure load training to improve aerobic capacity in advanced COPD: a substudy of the randomised, controlled EPT trial

Cardiorespiratory response of the incremental step test in people with chronic obstructive pulmonary disease

CPET vs PFTs for lung cancer surgery: which is a better indicator of pre-surgical functional status?

Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up